Summary of the Analytical Method Development Case Study
- The Analytical Method Development Case Study showcases a 50% reduction in assay time using optimized HPLC method development.
- Applied a rigorous analytical method development strategy for faster, more accurate results.
- Improved efficiency without compromising precision, sensitivity, or regulatory compliance.
- Real-world example from ResolveMass Laboratories demonstrating deep industry expertise.
- Highlights how strategic method optimization can save significant time and costs in pharmaceutical analysis.
Introduction: Why Analytical Method Development Matters in HPLC
At ResolveMass Laboratories Inc., we recently completed an Analytical Method Development Case Study where we reduced HPLC assay time from 40 minutes to just under 20 minutes. In regulated pharmaceutical and biotechnology labs, speed matters only if quality and compliance remain intact. Our goal was to make the process faster without losing precision, reproducibility, or meeting global standards like ICH, USP, and EMA.
This project was not only about making tests quicker—it was proof of our ability to balance performance and compliance. With a scientific yet practical approach, we ensured that the method worked well for both laboratory use and production needs. This reinforces our reputation as a trusted partner for solving complex analytical challenges.
For more information on our method development services, visit:
- Analytical Method Development
- Method Development for Complex APIs
- Custom Analytical Method Development
Project Background
A mid-sized pharmaceutical manufacturer came to us needing faster quality control testing for an Active Pharmaceutical Ingredient (API). Their original HPLC method was accurate but too slow, delaying product release and affecting production schedules. The main challenge was to speed up testing without losing accuracy or data integrity.
We had to work within strict ICH guidelines, keep sensitivity the same, and ensure the new method worked with their existing equipment. Our custom optimization plan met all these requirements, making it easy for the client to switch to the faster method without disruption.
Analytical Method Development Process Overview
Our team followed the ResolveMass Laboratories five-step workflow for analytical method development:
| Step | Activity | Objective |
|---|---|---|
| 1 | Method Assessment | Find inefficiencies in the current assay |
| 2 | Experimental Design | Use Design of Experiments (DoE) to test multiple parameters |
| 3 | Optimization | Adjust flow rate, gradient, and column chemistry |
| 4 | Validation | Confirm precision, accuracy, and robustness |
| 5 | Implementation | Integrate the improved method into production |
By using DoE, we tested different factors at the same time, saving development time and avoiding trial-and-error. Every change we made had a measurable, positive impact on performance.
Read more:
Optimization Strategies in the Analytical Method Development Case Study
Flow Rate and Gradient Adjustments
We increased the flow rate without exceeding the column’s pressure limits and adjusted the gradient profile to maintain resolution. This reduced run time while keeping peak quality intact. These steps alone cut down a big portion of the total assay time. By carefully balancing these parameters, we ensured the method could run faster without introducing any risk of data inconsistency.
Column Selection
Switching to a smaller particle size C18 column improved separation efficiency, allowing shorter retention times. The new column gave sharper peaks and better precision while still being compatible with the existing HPLC system. This upgrade also allowed for more reproducible results across multiple batches, further improving method reliability.
Mobile Phase Optimization
We changed the buffer composition in the mobile phase to reduce equilibration time and improve peak shape. This allowed consistent results even at higher flow rates, helping keep the method stable and reliable. The optimized mobile phase also reduced baseline noise, making it easier to detect even low-concentration components.
Results of the Analytical Method Development Case Study
The optimized method reduced assay time from 40 minutes to just 19 minutes—a 52.5% improvement—while keeping resolution, precision, and regulatory compliance intact.
Performance Before & After Optimization
| Parameter | Before | After |
|---|---|---|
| Assay Time | 40 min | 19 min |
| Resolution (Rs) | 2.5 | 2.4 |
| %RSD | 0.9 | 1.0 |
| Compliance | ICH Q2(R1) | ICH Q2(R1) |
This improvement met the client’s needs and provided a scalable solution for future testing.
Cost and Efficiency Benefits
The new method used less instrument time, reduced solvent consumption by 45%, and sped up QC release times. Overall, the client saved around 30% in annual operational costs. These gains also meant less environmental waste, supporting sustainability goals while boosting productivity.
Learn more:
Why This Case Study Proves Our Expertise
Experience: Extensive experience in HPLC method development for pharma and biotech.
Expertise: Methods developed to meet ICH, USP, and EMA standards.
Authority: Trusted by clients across North America for complex analytical solutions.
Trust: Transparent validation and full documentation build client confidence.
Conclusion
This Analytical Method Development Case Study shows how we reduced HPLC assay time by over 50% without losing quality or compliance. Using a structured, science-driven approach, we provided a faster, more cost-effective testing solution that improved operational efficiency.
By combining innovation with strict quality standards, ResolveMass Laboratories proves that method optimization can boost both speed and reliability. For pharmaceutical companies, this means quicker batch release, lower costs, and confidence in every test result.
Explore our related services:
FAQs on Analytical Method Development Case Study
The main aim is to create a method that delivers accurate, precise, and repeatable results. At the same time, it should be efficient enough to save time and resources while meeting all compliance requirements. This balance is key to ensuring reliable results in real-world applications.
We strictly follow international guidelines such as ICH Q2(R1) at every step of the process. After optimization, the method is fully validated to confirm that it meets all regulatory standards. This ensures it can be confidently used in regulated environments like pharmaceuticals.
Yes, it is possible when changes are made with a careful scientific approach. By adjusting parameters such as flow rate, gradient, and column type, run time can be reduced while maintaining the same high level of accuracy. Each change is tested to confirm quality is not compromised.
Choosing the right column chemistry is crucial because it affects separation efficiency and resolution. With the right column, run times can be significantly shorter without losing clarity in results. This makes column selection a key factor in HPLC optimization.
Absolutely. Even after a successful optimization, validation is essential to prove the method is accurate, precise, and robust. This step also ensures compliance with regulatory expectations before the method is put into routine use.
Request Your Analytical Method Development Quote
References
- European Medicines Agency. (2024, June 14). ICH Q2(R2) Validation of analytical procedures – Scientific guideline. European Medicines Agency. https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures-scientific-guideline
- Rina, R., Baile, M., & Jain, A. (2021). A review: Analytical method development and validation. Systematic Reviews in Pharmacy, 12(8), 450–454. https://www.sysrevpharm.org/articles/a-review-analytical-method-development-and-validation.pdf
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2023). Validation of analytical procedures: Q2(R2). https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf
